Sanofi's quarterly profit boosted by Dupixent and newer drugs, forecast unchanged
Sanofi(US:SNY) Reuters·2025-10-24 13:35公司业绩表现 - 公司第三季度利润超出分析师预期[1] - 业绩受到抗炎药Dupixent和新药强劲需求的推动[1]
Sanofi(US:SNY) Reuters·2025-10-24 13:35Sanofi(US:SNY) Reuters·2025-10-24 13:35